Both in Biotechnology
BioCardia vs Passage Bio
Over the past year BCDA returned −26.4% and PASG returned −43.1%; their daily moves had a correlation of 0.05.
BCDA −26.4% PASG −43.1%Growth of $1, one year, split-adjusted
| Metric | BCDA | PASG |
|---|---|---|
| Price | $1.03 | $4.63 |
| Market cap | $15.6M | $14.9M |
| Today | −0.96% | −0.96% |
| 1 month | −10.4% | +2.4% |
| 6 months | −11.2% | −25.1% |
| Year to date | −17.6% | −60.8% |
| 1 year | −27.5% | −42.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.1M | $24.2M |
| Dividend yield | — | — |
| Volatility (60d) | 79.6% | 49.0% |
| Short % of float | 10.6% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).